Home Spear Bio

Spear Bio

In operation
Series A
Developer of Ultra-Sensitive Protein Detection Technology
Basic
Enterprise Profile

Basic Information

Spear Bio's immunoassay technology, developed by Harvard University scientists, enables ultra-sensitive detection from small sample volumes and is compatible with existing sample collection, processing, and testing workflows. Ultra-sensitive immunoassays, capable of biomarker discovery, early detection, and home collection, are driving goals for researchers and clinicians advancing the field of proteomics.
Spear Bio Inc.
Massachusetts,United States of America
15~50 people
January 01, 2021
info@spear.bio

Enterprise Profile

Industrial Sector
Medical Device R&D and Design Clinical Trial Institution Scientific Research and Experimental Development Services
Technology
In Vitro Diagnostics Immunological Techniques Protein Technology
Concept
Laboratory Diagnosis Department of Clinical Laboratory
Application Scenarios
Medical Device Consumables